Ratings by Cantor Fitzgerald (Louise Chen)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/28/2021 Hutchison China MediTech Ltd. HCM Maintain Overweight
(N/A)
 
 
  Details
7/27/2021 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Hutchison China MediTech Ltd. HCM Maintain Overweight
(N/A)
 
 
  Details
7/13/2021 Cutera CUTR Maintain Overweight
(N/A)
 
 
  Details
7/7/2021 Jaguar Animal Health JAGX New Coverage Overweight
(N/A)
1.49
(1.36)
-8.72% Details
6/28/2021 PDS Biotechnology Corp PDSB New Coverage Overweight
(N/A)
11.00
(11.14)
1.27% Details
6/24/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
6/11/2021 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/9/2021 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
6/4/2021 Cerecor CERC New Coverage Overweight
(N/A)
2.73
(2.68)
-1.83% Details
6/2/2021 Cutera CUTR New Coverage Overweight
(N/A)
40.86
(51.79)
26.75% Details
5/13/2021 Soliton SOLY Downgrade Neutral
(Overweight)
22.39
(21.90)
-2.19% Details
4/16/2021 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
4/6/2021 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
4/6/2021 Soliton SOLY Maintain Overweight
(N/A)
 
 
  Details
3/10/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
3/5/2021 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
2/22/2021 Evolus EOLS Maintain Overweight
(N/A)
 
 
  Details
2/22/2021 Humanigen HGEN Maintain Overweight
(N/A)
 
 
  Details
2/4/2021 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
2/2/2021 Soliton SOLY Maintain Overweight
(N/A)
 
 
  Details
2/2/2021 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
1/29/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
1/26/2021 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
1/19/2021 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
1/6/2021 SCYNEXIS SCYX New Coverage Overweight
(N/A)
7.17
(6.65)
-7.25% Details
1/5/2021 Ardelyx, Inc ARDX New Coverage Overweight
(N/A)
6.47
(6.47)
0% Details
1/5/2021 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
12/28/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
11/5/2020 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
10/26/2020 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
10/21/2020 Humanigen HGEN New Coverage Overweight
(N/A)
13.44
(16.00)
19.05% Details
9/9/2020 Entasis Therapeutics ETTX New Coverage Overweight
(N/A)
2.76
(2.28)
-17.39% Details
9/8/2020 I-Mab IMAB Maintain Overweight
(N/A)
 
 
  Details
9/8/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/6/2020 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
8/4/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/3/2020 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
7/27/2020 I-Mab IMAB New Coverage Overweight
(N/A)
29.93
(76.85)
156.77% Details
7/23/2020 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
7/15/2020 Soliton SOLY New Coverage Overweight
(N/A)
7.34
(21.90)
198.37% Details
7/9/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/15/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/9/2020 ContraFect Corp. CFRX New Coverage Overweight
(N/A)
5.04
(3.92)
-22.22% Details
6/1/2020 Pfizer PFE Maintain Overweight
(N/A)
 
 
  Details
5/22/2020 Evolus EOLS Maintain Overweight
(N/A)
 
 
  Details
4/28/2020 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
4/24/2020 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
4/14/2020 Amarin Corporation AMRN Maintain Overweight
(Overweight)
 
 
  Details
4/3/2020 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
3/19/2020 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
2/25/2020 Arcutis Biotherapeutics Inc. ARQT New Coverage Overweight
(N/A)
27.05
(20.80)
-23.11% Details
2/24/2020 Aravive Inc. ARAV Maintain Overweight
(Overweight)
 
 
  Details
2/18/2020 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
2/12/2020 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
1/29/2020 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
1/27/2020 Aridis Pharmaceuticals ARDS Maintain Overweight
(N/A)
 
 
  Details
1/27/2020 Cidara Therapeutics CDTX Maintain Overweight
(N/A)
 
 
  Details
1/23/2020 Johnson & Johnson JNJ Maintain Overweight
(Overweight)
 
 
  Details
1/21/2020 Perrigo Co. PRGO Maintain Overweight
(N/A)
 
 
  Details
1/13/2020 Perrigo Co. PRGO Maintain Overweight
(N/A)
 
 
  Details
1/13/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Horizon Therapeutics HZNP Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
1/9/2020 Johnson & Johnson JNJ Maintain Overweight
(N/A)
 
 
  Details
1/8/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/8/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/7/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
1/2/2020 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/20/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/10/2019 Aravive Inc. ARAV New Coverage Overweight
(N/A)
10.73
(4.06)
-62.16% Details
12/2/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/2/2019 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
11/20/2019 Johnson & Johnson JNJ New Coverage Overweight
(N/A)
134.83
(173.36)
28.58% Details
11/14/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
11/8/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
11/6/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
10/29/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
10/17/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/25/2019 TherapeuticsMD TXMD Maintain Overweight
(N/A)
 
 
  Details
9/20/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/16/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/11/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/9/2019 Eli Lilly LLY Maintain Overweight
(Overweight)
 
 
  Details
9/3/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/15/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
8/15/2019 TherapeuticsMD TXMD Maintain Overweight
(N/A)
 
 
  Details
8/15/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
8/9/2019 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
8/7/2019 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
8/6/2019 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
7/31/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/29/2019 Mylan MYL Maintain Overweight
(N/A)
 
 
  Details
7/24/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/24/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/16/2019 Spero Therapeutics SPRO Maintain Overweight
(N/A)
 
 
  Details
7/12/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
7/12/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/11/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
7/2/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/14/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 TherapeuticsMD TXMD Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Perrigo Co. PRGO Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Neos Therapeutics NEOS Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Mylan MYL Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Mallinckrodt plc MNK Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Endo International plc ENDP Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Cidara Therapeutics CDTX Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Amneal Pharmaceuticals AMRX Maintain Overweight
(N/A)
 
 
  Details
6/12/2019 Allergen AGN Maintain Neutral
(N/A)
 
 
  Details
6/12/2019 Aclaris Therapeutis ACRS Maintain Overweight
(N/A)
 
 
  Details
5/31/2019 Bausch Health Companies BHC Maintain Overweight
(N/A)
 
 
  Details
5/31/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
5/29/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
5/2/2019 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
4/8/2019 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
4/3/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
4/2/2019 Foamix Pharmaceuticals FOMX Maintain Overweight
(N/A)
 
 
  Details
4/2/2019 Mylan MYL Maintain Neutral
(N/A)
 
 
  Details
4/1/2019 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
4/1/2019 Merck MRK Maintain Overweight
(N/A)
 
 
  Details
3/28/2019 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
3/28/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
3/25/2019 Dermira DERM Maintain Overweight
(N/A)
 
 
  Details
3/18/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
3/12/2019 Theravance Biopharma TBPH Maintain Overweight
(N/A)
 
 
  Details
2/27/2019 Horizon Pharma HZNP Maintain Overweight
(N/A)
 
 
  Details
2/22/2019 Merck MRK New Coverage Overweight
(N/A)
79.43
(75.48)
-4.97% Details
2/12/2019 Dermira DERM Maintain Overweight
(N/A)
 
 
  Details
2/6/2019 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
1/25/2019 Foamix Pharmaceuticals FOMX Maintain Overweight
(N/A)
 
 
  Details
1/11/2019 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
12/27/2018 Aridis Pharmaceuticals ARDS Maintain Overweight
(N/A)
 
 
  Details
11/30/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
11/13/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
10/19/2018 Endo International plc ENDP Maintain Neutral
(Neutral)
 
 
  Details
10/17/2018 Zoetis Inc. ZTS Maintain Overweight
(N/A)
 
 
  Details
10/17/2018 Eli Lilly LLY Maintain Overweight
(N/A)
 
 
  Details
10/17/2018 Pfizer PFE Maintain Overweight
(Overweight)
 
 
  Details
10/12/2018 Foamix Pharmaceuticals FOMX New Coverage Overweight
(N/A)
5.00
(2.99)
-40.2% Details
10/4/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/27/2018 Heron Therapeutics HRTX Maintain Overweight
(N/A)
 
 
  Details
9/27/2018 Teva Pharma TEVA Maintain Neutral
(N/A)
 
 
  Details
9/26/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/24/2018 Amarin Corporation AMRN Maintain Overweight
(N/A)
 
 
  Details
9/10/2018 Aridis Pharmaceuticals ARDS New Coverage Overweight
(N/A)
13.30
(4.29)
-67.74% Details
9/7/2018 Menlo Therapeutics MNLO New Coverage Overweight
(N/A)
7.60
(1.35)
-82.24% Details
9/5/2018 Dermira DERM Maintain Overweight
(N/A)
 
 
  Details